Generics Industry News Search
 |
|
|
|
|
|
|
July 2004 News Archive |
|
|
| |
|
N.J., July 1: Barr Pharmaceuticals, Inc. today announced that the U.S. District Court in New Jersey has granted summary judgment of noninfringement of three patents in Barr Laboratories, Inc.'s patent challenge litigation involving Allegra(R) (Fexofenadine Hydrochloride) ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
PITTSBURGH, Jul 2, 2004: Mylan Laboratories Inc. announced today that it has entered into a settlement and license agreement ending its paclitaxel litigation with Mayne Pharma (USA) Inc., formerly known as Faulding Pharmaceutical Co., and Tapestry Pharmaceuticals Inc., ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
N.J., July 2: Barr Pharmaceuticals, Inc. today announced that Barr Laboratories, Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its generic version of Aventis Pharmaceuticals' Allegra(R)-D (Fexofenadine HCl 60mg and Pseudoephedrine HCl 120mg)...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
London, July 8, 2004: GlaxoSmithKline today announced that it has agreed to settle US anti-trust cases involving the antibiotic product Augmentin. GSK will pay US$92 in settlement of class action lawsuits brought on behalf of direct purchasers, ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
PITTSBURGH, July 14: Mylan Laboratories Inc. today announced that the U.S. Food and Drug Administration has granted approval for the company to market its currently approved Levothyroxine Sodium Tablets as a bioequivalent and therapeutically equivalent (i.e., AB-rated) product to Jones Pharma Inc.'s Levoxyl(R) Tablets....
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
SCHAUMBURG, Ill., July 16, 2004: American Pharmaceutical Partners, Inc. announced that it has received approval from the U.S. Food and Drug Administration to launch a 40g vial of Piperacillin for Injection, USP, the generic equivalent of Wyeth's Pipracil®. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Jerusalem, Israel, July 21, 2004:Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has granted final approval for the Company's ANDA for Terbutaline Sulfate Injection, 1 mg/mL...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
PITTSBURGH, and BRISTOL, Tenn., July 26; Mylan Laboratories Inc.) and King Pharmaceuticals, Inc. two S&P; 500 companies, today announced that they have signed a definitive agreement under which Mylan will acquire King in a stock-for-stock transaction...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
New Jersey, July 27, 2004: Alpharma was today notified that the United States Court of Appeals for the District of Columbia has ordered that the Food and Drug Administration's final approval for Alpharma's gabapentin capsule ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Jerusalem, Israel, July 29, 2004 - Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has granted final approval for the Company's ANDA for Medroxyprogesterone Acetate Injectable Suspension USP, 150 mg/mL in single-dose vials. ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Jerusalem, Israel, July 29, 2004 - Teva Pharmaceutical Industries Ltd. (announced today that the U.S. Food and Drug Administration has granted final approval for the Company's ANDAs for Fluconazole Tablets, 50 mg, 100 mg, 150 mg and 200 mg and Fluconazole Injection, ...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Spring Valley, New York, June 30, 2004 - Par Pharmaceutical Companies, Inc. today announced that its wholly-owned subsidiary, Kali Laboratories, Inc., has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for nystatin topical powder (100,000 units/gram). ...
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|
Home
